Global Balloon Valvuloplasty Device Market Poised for 5.7% Growth, Surpassing $3.23 Billion by 2029


The balloon valvuloplasty device market size has grown strongly in recent years. It will grow from $2.44 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%.  The growth in the historic period can be attributed to increasing healthcare expenditure, expansion of healthcare infrastructure, improved awareness and diagnostic capabilities, preference for outpatient settings, growth of telemedicine enhancing access, and emphasis on improving quality of life for patients.

The balloon valvuloplasty device market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the increasing prevalence of heart valve diseases among elderly populations worldwide, increasing adoption of less invasive treatments for heart valve conditions, accelerated approvals and clearances for new balloon valvuloplasty devices, and focus on cost-effective healthcare solutions. Major trends in the forecast period include enhanced imaging modalities aiding in precise diagnosis, personalized medicine approaches, increasing research and development investments, growth of regenerative techniques in cardiovascular disease management, and integration of digital health technologies.

 

Get Your Free Sample of The Global Balloon Valvuloplasty Device Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17090&type=smp

How have varous drivers impacted the growth of the balloon valvuloplasty device market?
The rising inclination towards minimally invasive procedures is expected to propel the growth of the balloon valvuloplasty device market going forward. Minimally invasive procedures refer to medical techniques performed through small incisions or natural body openings, reducing trauma and promoting faster recovery compared to traditional surgeries. The demand for minimally invasive procedures is on the rise due to their reduced recovery times, lower risk of complications, and lower post-operative pain compared to traditional surgeries. Balloon valvuloplasty devices are used in minimally invasive surgical procedures to widen narrowed heart valves, improve blood flow, and reduce symptoms. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the rising inclination towards minimally invasive procedures is driving the growth of the balloon valvuloplasty device market.

What are the primary segments of the balloon valvuloplasty device market?
The balloon valvuloplasty device market covered in this report is segmented –
1) By Product Type: Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon
2) By Age Group: Pediatric, Adult
3) By End-use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:
1) By Standard Balloon: Non-Compliant Balloons, Compliant Balloons
2) By Cutting Balloon: Single-Cutting Balloon, Multi-Cutting Balloon
3) By Scoring Balloon: Single-Score Balloons, Dual-Score Balloons
4) By High-Pressure Balloon: Non-Compliant High-Pressure Balloons, Compliant High-Pressure Balloons
5) By Low-Pressure Balloon: Semi-Compliant Low-Pressure Balloons, Non-Compliant Low-Pressure Balloons



Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/balloon-valvuloplasty-device-global-market-report

Which firms are leading the balloon valvuloplasty device market?
Major companies operating in the balloon valvuloplasty device market are  Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Philips Healthcare, Becton Dickinson Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Cordis Corporation, NuMED Inc., Pfm Medical GmbH, Tokai Medical Products Inc, Translumina GmbH, Meril Life Sciences Pvt. Ltd., Toray Medical Company Limited, QT Vascular Ltd.

How will industry trends affect the trajectory of the balloon valvuloplasty device market?
Major companies operating in the balloon valvuloplasty device market are focusing on developing advanced products, such as Pacing Guidewires, to gain a competitive edge in the market. A pacing guidewire is a specialized wire used to provide temporary cardiac pacing during the procedure, ensuring the heart maintains a stable rhythm while the balloon catheter is inserted and inflated to dilate the narrowed valve. For instance, in June 2023, Teleflex Incorporated, a US-based medical device company,  received clearance from the Food and Drug Administration (FDA) for the Wattson Temporary Pacing Guidewire. This new device is designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV) procedures. The Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during these structural heart procedures. Its flexible distal pigtail shape, multiple electrodes, and bipolar design are engineered to help reduce the risk of ventricular perforation while providing reliable electrical capture during rapid pacing.

Which geographic trends are shaping the balloon valvuloplasty device market, and which region has the highest market share?
North America was the largest region in the balloon valvuloplasty device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon valvuloplasty device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Balloon Valvuloplasty Device Market Report 2025 Offer?
The balloon valvuloplasty device market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

A balloon valvuloplasty device is a medical instrument used to treat heart valve stenosis by inserting a balloon into the narrowed valve and inflating it to widen the opening, improving blood flow. This non-surgical procedure is minimally invasive and aims to relieve symptoms such as chest pain and shortness of breath, enhancing cardiac function and patient quality of life.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17090

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model 


Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Image
  The drugs for benign prostatic hypertrophy market size has grown strongly in recent years. It will grow from $4.28 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, increased awareness, advancements in drug therapies, healthcare access. The drugs for benign prostatic hypertrophy market size is expected to see strong growth in the next few years. It will grow to $5.58 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to emerging markets, new drug developments, increasing awareness and education, regulatory approvals. Major trends in the forecast period include minimally invasive treatments, personalized medicine, combination therapies, patient-centered care, telemedicine and digital health, research and development. #Download Your Free Sample PDF:# https://www.thebusinessresearchcompany.com/sample.a...
Read more